摘要
在资本和劳动两种生产要素基础上引入知识存量要素,用DEA和SFA方法分别对2006—2010年我国20家上市生物制药企业的技术效率进行测算,并系统分析生物制药企业技术效率的影响因素。结果显示,DEA和SFA两种方法对生物制药企业技术效率测算结果一致;技术知识存量的增加有利于提高企业主营业务收入;提高新药和专利数、扩大国有股权比例、提高科研机构合作水平和扩宽融资渠道对提高企业的技术效率有正面影响。
Based on DEA and SFA approaches and on the sample of dozens of the listed biopharmaceutical enterprises during 2006 to 2010, the paper makes a study on the firm＇ s technical efficiency by adding the stock of knowledge to the labors arid assets. The empirical results show that the accumulation of knowledge is of benefit to the incomes of the main business of the companies. The increase number of new medicine and patens, the enlarge size of the company keeps collabora- ting with the institution and broadens the financing channels, which are good the technical efficiency. Both the DEA and SFA approaches come to the same results in testing the technical efficiency of the biopharmaceutical enterprises.
出处
《科技管理研究》
CSSCI
北大核心
2013年第2期93-96,共4页
Science and Technology Management Research
关键词
知识存量
技术效率
DEA
SFA
the stock of knowledge
technology efficiency
DEA
SFA
